Novel myostatin-specific antibody enhances muscle strength in muscle disease models
Abstract Myostatin, a member of the transforming growth factor-β superfamily, is an attractive target for muscle disease therapy because of its role as a negative regulator of muscle growth and strength. Here, we describe a novel antibody therapeutic approach that maximizes the potential of myostati...
Guardado en:
Autores principales: | Hiroyasu Muramatsu, Taichi Kuramochi, Hitoshi Katada, Atsunori Ueyama, Yoshinao Ruike, Ken Ohmine, Meiri Shida-Kawazoe, Rie Miyano-Nishizawa, Yuichiro Shimizu, Momoko Okuda, Yuji Hori, Madoka Hayashi, Kenta Haraya, Nobuhiro Ban, Tatsuya Nonaka, Masaki Honda, Hidetomo Kitamura, Kunihiro Hattori, Takehisa Kitazawa, Tomoyuki Igawa, Yoshiki Kawabe, Junichi Nezu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f5532204ebd94faaa523b4801829ed1c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Plasma and muscle myostatin in relation to type 2 diabetes.
por: Claus Brandt, et al.
Publicado: (2012) -
JNK regulates muscle remodeling via myostatin/SMAD inhibition
por: Sarah J. Lessard, et al.
Publicado: (2018) -
Proteomic Studies on the Mechanism of Myostatin Regulating Cattle Skeletal Muscle Development
por: Hui Sheng, et al.
Publicado: (2021) -
Deficiency of myostatin protects skeletal muscle cells from ischemia reperfusion injury
por: Christoph Wallner, et al.
Publicado: (2021) -
Pharmacological inhibition of myostatin improves skeletal muscle mass and function in a mouse model of stroke
por: Marine Maud Desgeorges, et al.
Publicado: (2017)